More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Shelled Eggs
Antitrust, Commodities
On June 8, Lowey Dannenberg Chairman Vincent Briganti was appointed as Co-Lead Counsel for the Direct Purchaser Plaintiffs in In Re: Shell Eggs Antitrust Litigation, No. 3:26-md-03175-JDP (W.D. Wisc.) Plaintiffs […]
Amitza
Healthcare
Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. […]
Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
News
SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Files Securities Class Action Lawsuit on Behalf of Investors Who Acquired U.S. Bancorp Securities from August 1, 2019 to July 28, 2022, Inclusive, and Encourages Investors to Inquire About the Lead Plaintiff Position Before the December 26, 2022 Deadline
NEW YORK, NY / ACCESSWIRE / October 26, 2022 / Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, has filed a federal securities class action in the United States District Court Southern District of New York on behalf…
Blog
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.